@bedger, agree with everything you said. I was referring (tongue in cheek) to the drop in short term share price. These conferences happen when they happen. Given its subject, you would hope that given our position as market leading, that the conference would want to hear from Mr Mesoblast. He has a good story to tell, but the only story that the market and the majority of shareholders want to hear is approvals at this time. There will come a time when we have some big selling therapies out there, that a look into the cupboard marked “future therapies” will be important. IBS news will move the market, particularly when we have a more positive sentiment. For that we need the good news, approval news. EUA, AA or approval, I’ll take any. Off with the dog now, have a great weekend. Enjoy following your posts. regards Yelrom
MSB Price at posting:
$1.93 Sentiment: Hold Disclosure: Held
(20min delay)